The international European Academy of Neurology survey on neurological symptoms in patients with COVID‐19 infection
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Background and purpose: Although the main clinical features of COVID‐19 infection are pulmonary, several associated neurological signs, symptoms and diseases are emerging. The incidence and characteristics of neurological complications are unclear. For this reason, the European Academy of Neurology (EAN) core COVID‐19 Task Force initiated a survey on neurological symptoms observed in patients with COVID‐19 infection. Methods: A 17‐question online survey was made available on the EAN website and distributed to EAN members and other worldwide physicians starting on 9 April 2020. Results: By 27 April 2020, proper data were collected from 2343 responders (out of 4199), of whom 82.0% were neurologists, mostly from Europe. Most responders (74.7%) consulted patients with COVID‐19 mainly in emergency rooms and in COVID‐19 units. The majority (67.0%) had evaluated fewer than 10 patients with neurological manifestations of COVID‐19 (neuro COVID‐19). The most frequently reported neurological findings were headache (61.9%), myalgia (50.4%), anosmia (49.2%), ageusia (39.8%), impaired consciousness (29.3%) and psychomotor agitation (26.7%). Encephalopathy and acute cerebrovascular disorders were reported at 21.0%. Neurological manifestations were generally interpreted as being possibly related to COVID‐19; they were most commonly recognized in patients with multiple general symptoms and occurred at any time during infection. Conclusion: Neurologists are currently and actively involved in the management of neurological issues related to the COVID‐19 pandemic. This survey justifies setting up a prospective registry to better capture the prevalence of patients with neuro COVID‐19, neurological disease characteristics and the contribution of neurological manifestations to outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166 · cited 3×
“Indeed, besides classical respiratory symptoms and signs (cough, dyspnoea and pyrexia), renal, gastrointestinal, dermatological and neurological manifestations have been described [7,8].”
BackgroundResultIncidence of thrombotic complications in critically ill ICU patients with COVID-19
Klok, F. A., Kruip, M. J. H. A., van der Meer, N. J. M., Arbous, M. S., Gommers, D. A. M. P. J., Kant, K. M., Kaptein, F. H. J., van Paassen, J., Stals, M. A. M., Huisman, M. V., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.013 · Cited by 5,028 · cited 1×
“The occurrence of thrombotic complications has been documented in 31% of ICU patients with COVID-19 [32].”
BackgroundNeurologic features in severe SARS-CoV-2 infection
Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2008597 · Cited by 2,674
Lechien, J. R., Chiesa-Estomba, C. M., De Siati, D. R., Horoi, M., Le Bon, S. D., Rodriguez, A., Dequanter, D., Blecic, S., El Afia, F., Distinguin, L., et al. (2020) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-020-05965-1 · Cited by 2,668 · cited 1×
“These findings are in line with previous reports [22] which have suggested that these symptoms are due to direct effects of the virus on the olfactory system [23] and gustatory receptors [24].”
ResultLi, Y., Bai, W., & Hashikawa, T. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25728 · Cited by 2,266
Neurological associations of COVID-19
Ellul, M. A., Benjamin, L., Singh, B., Lant, S., Michael, B. D., Easton, A., Kneen, R., Defres, S., Sejvar, J., & Solomon, T. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30221-0 · Cited by 2,156
Nervous system involvement after infection with COVID-19 and other coronaviruses
Wu, Y., Xu, X., Chen, Z., Duan, J., Hashimoto, K., Yang, L., Liu, C., & Yang, C. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.03.031 · Cited by 2,046 · cited 1×
“Coronaviruses can invade nervous tissues, involving macrophages, microglia, astrocytes [20], and cause nerve damage not only through direct infection pathways (both circulatory and neuronal) but also through secondary hypoxia, immune-mediated injuries, attack to enzymes involved in the renin-angiotensin system, and ot…”
BackgroundMultiorgan and Renal Tropism of SARS-CoV-2
Puelles, V. G., Lütgehetmann, M., Lindenmeyer, M. T., Sperhake, J. P., Wong, M. N., Allweiss, L., Chilla, S., Heinemann, A., Wanner, N., Liu, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2011400 · Cited by 1,775 · cited 1×
“Indeed, COVID-19 viral load has been found in the brain tissue samples of patients who died during the pandemic [17,21].”
BackgroundDesforges, M., Le Coupanec, A., Dubeau, P., Bourgouin, A., Lajoie, L., Dubé, M., & Talbot, P. J. (2019) · Viruses · doi:10.3390/v12010014 · Cited by 1,048 · cited 1×
“Coronaviruses may also enter the brain through the olfactory tract in the early stages of infection [25].”
BackgroundGiannis, D., Ziogas, I. A., & Gianni, P. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104362 · Cited by 893 · cited 1×
“Depletion of ACE2 by SARS-CoV-2 may enhance the activity of the ACE1/angiotensin II axis and promote tissue injury, predisposing to occurrence of stroke [33,34].”
Background
Cited by
Chou, S. H.-Y., Beghi, E., Helbok, R., Moro, E., Sampson, J., Altamirano, V., Mainali, S., Bassetti, C., Suarez, J. I., McNett, M., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.12131 · Cited by 407
Self-citationBrainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung
Bulfamante, G., Bocci, T., Falleni, M., Campiglio, L., Coppola, S., Tosi, D., Chiumello, D., & Priori, A. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10604-8 · Cited by 83
Self-citationNon-Contact SpO2 Prediction System Based on a Digital Camera
Al-Naji, A., Khalid, G. A., Mahdi, J. F., & Chahl, J. (2021) · Applied Sciences · doi:10.3390/app11094255 · Cited by 61
Otero-Losada, M., Petrovsky, N., Alami, A., Crispo, J. A., Mattison, D., Capani, F., Goetz, C., Krewski, D., & Perez-Lloret, S. (2023) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2120607 · Cited by 22
Metadata
- Authors
- Moro, E., Priori, A., Beghi, E., Helbok, R., Campiglio, L., Bassetti, C. L., Bianchi, E., Maia, L. F., Ozturk, S., Cavallieri, F., Zedde, M., Sellner, J., Bereczki, D., Rakusa, M., Di Liberto, G., Sauerbier, A., Pisani, A., Macerollo, A., Soffietti, R., Taba, P., Crean, M., Twardzik, A., Oreja‐Guevara, C., Bodini, B., Jenkins, T. M., von Oertzen, T. J., & for the EAN core COVID‐19 Task Force
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2020-07-23
- Volume
- 27
- Issue
- 9
- Pages
- 1727-1737
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W3036631414
- Cited by
- 111
- References
- 15
- FWCI
- 9.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.